No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - General
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.
www.otsuka.comNo one on the platform currently holds 4578.T.
No tracked institution reports a position in 4578.T as of their last filing.
No one on the platform has traded 4578.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.8% | 9.3% | 7.6% | — | — | — |
| Rev. Growth % | 6.0% | 11.7% | ||||
| Profit Margin % | 14.7% | 10.3% | 9.4% | |||
| Free Cash Flow Margin % | 12.8% | 10.8% | 9.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.75T | +13.3% | $704.30 | $665.61–$729.09 | — | 12 |
| 2027 | $2.81T | +2.2% | $717.47 | $659.44–$837.81 | — | 12 |
| 2028 | $2.94T | +4.6% | $835.30 | $702.96–$1029.33 | — | 11 |
| 2029 | $3.07T | +4.1% | $952.35 | $894.80–$987.01 | — | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $163.92 | $222.76 | +35.9% |
| 2026-04-28 | $134.24 | $183.01 | +36.3% |
| 2026-02-13 | $74.77 | $124.25 | +66.2% |
| 2025-10-29 | $161.90 | $245.17 | +51.4% |
| 2025-07-30 | $153.61 | $171.33 | +11.5% |
| 2025-04-28 | $112.63 | $152.93 | +35.8% |
| 2025-02-12 | $60.46 | $270.86 | +348.0% |
| 2024-10-31 | $186.72 |
| $154.72 |
| -17.1% |
| +1.80% |
| $2.47T |
| — |
| 4528.TOno Pharmaceutical Co., Ltd. | $2355.50 | +0.77% | $1.11T | — |
| 4536.TSanten Pharmaceutical Co., Ltd. | $1742.50 | -0.03% | $560.5B | — |
Source: Financial Modeling Prep · peers by sector/industry